Progressive Fibrosing Interstitial Lung Disease
📧 Sign up to get email alerts when something new happens for Progressive Fibrosing Interstitial Lung Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Study to Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients [Phase 2]
Phase 2 clinical trial investigating HEC585 to delay decline in forced vital capacity in progressive fibrosing interstitial lung disease, cu…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial [NA]
The OPTIMIZE-ILD-2 trial aims to optimize follow-up care for interstitial lung disease and fibrotic ILD, and it is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases. [NA]
A clinical trial is evaluating whether quercetin intake benefits patients with fibrotic interstitial lung diseases, including idiopathic pul…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Anlotinib Capsules in the Treatment for IPF/PF-ILDs [Phase 2, Phase 3]
Clinical trial update on Anlotinib capsules for idiopathic pulmonary fibrosis and progressive fibrosing interstitial lung disease. The Phase…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Hyperpolarized 129-Xenon MRI in Fibrosing Interstitial Lung Disease
A clinical trial update shows that the University of Aarhus is evaluating hyperpolarized 129-Xenon MRI in progressive fibrosing interstitial…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.